Bulls Look for Rebound at Edwards Lifesciences Corporation

Published: Oct 07, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Traders are looking for Edwards Lifesciences (EW_) to rebound after its synthetic heart valve won regulatory approval for broader use last week. About 3,700 October 75 calls were purchased for 20 cents to 75 cents on Friday, according to OptionMonster's tracking systems. The volume was well above the strike's previous open interest of 1,097 contracts, indicating that this is fresh buying.

Help employers find you! Check out all the jobs and post your resume.

Back to news